Paper1531329
The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.
Hiebert SW and 3 others. Genes Dev, 1992. Cited by 571 papers, by iCite.
Cite this record
ConductScience Library. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Papers, record 1531329. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1531329
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carrier Proteins | Major topic |
| Cell Cycle Proteins | Major topic |
| DNA-Binding Proteins | Major topic |
| Retinoblastoma Protein | Major topic |
| Transcription Factors | Major topic |
| Transcription, Genetic | Major topic |
| Adenovirus Early Proteins | |
| Antigens, Viral, Tumor | |
| Chloramphenicol O-Acetyltransferase | |
| E2F Transcription Factors | |
| Genes, Retinoblastoma | |
| HeLa Cells | |
| Humans | |
| Mutation | |
| Oncogene Proteins, Viral | |
| Precipitin Tests | |
| Promoter Regions, Genetic | |
| Recombinant Fusion Proteins | |
| Retinoblastoma-Binding Protein 1 | |
| Transcription Factor DP1 |
Source PubMed
Cited by261
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 571 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42587147 | Rb-driven transcription limits its tumour-suppressive effects in breast cancer. | Nature | 2026 | https://conductscience.org/library/papers/42587147 | PubMed |
| 40223929 | The multiple functions and mechanisms of long non-coding RNAs in regulating breast cancer progression. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40223929 | PubMed |
| 40069371 | Schisandrin B targets CDK4/6 to suppress proliferation and enhance radiosensitivity in nasopharyngeal carcinoma by inducing cell cycle arrest. | Sci Rep | 2025 | https://conductscience.org/library/papers/40069371 | PubMed |
| 39831611 | Regulation of cell cycle in plant gametes: when is the right time to divide? | Development | 2025 | https://conductscience.org/library/papers/39831611 | PubMed |
| 39820840 | Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2- Early Breast Cancer. | Drugs | 2025 | https://conductscience.org/library/papers/39820840 | PubMed |
| 39595534 | The N-Terminal Region of the Transcription Factor E2F1 Contains a Novel Transactivation Domain and Recruits General Transcription Factor GTF2H2. | Biomolecules | 2024 | https://conductscience.org/library/papers/39595534 | PubMed |
| 38926571 | An intermediate Rb-E2F activity state safeguards proliferation commitment. | Nature | 2024 | https://conductscience.org/library/papers/38926571 | PubMed |
| 38789411 | HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes. | Nat Commun | 2024 | https://conductscience.org/library/papers/38789411 | PubMed |
| 38781103 | PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer. | Mol Cancer Ther | 2024 | https://conductscience.org/library/papers/38781103 | PubMed |
| 38595981 | The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy. | Mol Ther Oncol | 2024 | https://conductscience.org/library/papers/38595981 | PubMed |
| 38082107 | The CDK4/6 inhibitor revolution - a game-changing era for breast cancer treatment. | Nat Rev Clin Oncol | 2024 | https://conductscience.org/library/papers/38082107 | PubMed |
| 37961464 | HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes. | bioRxiv | 2023 | https://conductscience.org/library/papers/37961464 | PubMed |
| 37699974 | Increased expression of HPV-E7 oncoprotein correlates with a reduced level of pRb proteins via high viral load in cervical cancer. | Sci Rep | 2023 | https://conductscience.org/library/papers/37699974 | PubMed |
| 37686364 | The Therapeutic Potential of CDK4/6 Inhibitors, Novel Cancer Drugs, in Kidney Diseases. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37686364 | PubMed |
| 37406085 | Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma. | Clin Cancer Res | 2023 | https://conductscience.org/library/papers/37406085 | PubMed |
| 36622663 | Apoptosis-modulatory miR-361-3p as a novel treatment target in endocrine-responsive and endocrine-resistant breast cancer. | J Endocrinol | 2023 | https://conductscience.org/library/papers/36622663 | PubMed |
| 36508448 | A Drosophila model of HPV16-induced cancer reveals conserved disease mechanism. | PLoS One | 2022 | https://conductscience.org/library/papers/36508448 | PubMed |
| 36096885 | E2F1/CKS2/PTEN signaling axis regulates malignant phenotypes in pediatric retinoblastoma. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/36096885 | PubMed |
| 35681587 | The Involvement of Human Papilloma Virus in Gastrointestinal Cancers. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35681587 | PubMed |
| 35621970 | The Inhibitors of CDK4/6 from a Library of Marine Compound Database: A Pharmacophore, ADMET, Molecular Docking and Molecular Dynamics Study. | Mar Drugs | 2022 | https://conductscience.org/library/papers/35621970 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ARID4A | 5926 | PubTator's text mining | https://conductscience.org/library/genes/5926 | NCBI Gene |
| E2F1 | 1869 | PubTator's text mining | https://conductscience.org/library/genes/1869 | NCBI Gene |
| RB1 | 5925 | PubTator's text mining | https://conductscience.org/library/genes/5925 | NCBI Gene |
| TFDP1 | 7027 | PubTator's text mining | https://conductscience.org/library/genes/7027 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1531329
GET https://conductscience.org/api/papers/v1/1531329/cited_by?page=2